ICZOOM reports 1H of fiscal year 2025 EPS 7c vs (7c) last year
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jun 20 2025
0mins
Fiscal Year 2025 Revenue: The company reported a revenue of $90.3 million for the first half of fiscal year 2025, an increase from $87.7 million in the same period last year.
Comparison to Previous Year: This marks a positive growth trend in revenue compared to the previous year's performance during the same timeframe.
Get Free Real-Time Notifications for Any Stock
Monitor tickers like IZM with instant alerts to capture every critical market movement.
Sign up for free to build your custom watchlist and receive professional-grade stock notifications.
Analyst Views on IZM
About IZM
ICZOOM Group Inc is a holding company mainly engaged in the sales of electronic components. The Company distributes its products primarily through its online platform www.iczoom.com. The Company's main electronic components include integrated circuits, discrete devices, passive components, optoelectronics, electromechanical, maintenance, repair and operations (MRO) and design tools. The Company's products are mainly used in consumer electronics industry, automotive electronics and industrial control fields. In addition, the Company also provides customers with temporary storage, logistics transportation and customs clearance services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split, Shares Plunge 38.4%
- Reverse Stock Split Announcement: Aptevo Therapeutics has announced a 1-for-18 reverse stock split effective December 29, converting every 18 shares into one, which has led to a significant 38.4% drop in share price to $0.57, indicating a negative market reaction despite prior shareholder approval in July.
- Severe Market Reaction: Following the reverse stock split announcement, Aptevo's shares plummeted sharply during Friday's session, reflecting investor concerns about the company's future prospects, which could adversely affect its financing capabilities and market confidence.
- Shareholder Approval Context: The final ratio for the reverse split was approved by the board in mid-December, despite having received shareholder support at the July annual meeting, yet the market's response raises questions about the company's governance and strategic direction.
- Industry Impact: The sharp decline in Aptevo's stock price may affect its competitive position in the biopharmaceutical sector, particularly regarding financing and partnership opportunities, as investors may reassess its investment value.
Continue Reading
ICZOOM Group Inc. Calls Extraordinary General Meeting to Vote on Management Changes
- Extraordinary Meeting Announcement: ICZOOM Group Inc. has scheduled an extraordinary general meeting for February 27, 2026, in response to a shareholder requisition dated December 5, 2025, aimed at voting on proposed changes to the management, thereby ensuring transparency and effectiveness in corporate governance.
- Shareholder Voting Rights: Shareholders of record as of February 2, 2026, will be entitled to vote, indicating the company's commitment to shareholder engagement and potentially enhancing governance standards through increased participation.
- Notice and Materials Distribution: The notice and related materials are expected to be mailed to shareholders on February 2, 2026, ensuring timely access to information and promoting transparency and engagement among shareholders.
- Future Implications: The convening of this meeting underscores the company's focus on management changes, which may influence future strategic directions and business decisions, thereby enhancing its competitiveness in the electronic components industry.
Continue Reading